(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Crowne Plaza Glasgow

Mar 28, 2017 8:30 AM - Mar 28, 2017 5:30 PM

Congress Rd, Glasgow, G3 8QT, United Kingdom

DIA Bioventure Day

Is the current Bioventure paradigm delivering return for patients and investors? This is the key question to be addressed by stakeholders from the funding, and from the innovating side.

Back to Agenda

Immuno-Oncology: Therapeutic Break Through Area or Nightmare for Health Care Funding

Session Chair(s)

Duane Schulthess, MBA

Duane Schulthess, MBA

Chief Executive Officer

Vital Transformation LLC, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.